Delivery Order SPE2DB20D2014-SPE2DB24FA13X
Award Date 10/19/23
Potential Completion Date 10/20/23
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Defense Logistics Agency awarded a $7,131.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse to be delivered by October 11, 2023. The place of performance will be Conshohocken, Pennsylvania. No set-aside provisions were applied to this contract action. Vyvanse is a prescription medication used to treat attention deficit hyperactivity disorder and binge eating disorder. This delivery order was awarded under an existing prime vendor agreement...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,814 to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 16-17, 2023. Vyvanse is a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder and binge eating disorder. This delivery order was issued under an...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,076 to Amerisourcebergen Drug Corporation for the supply of 100 Vyvanse 30 mg capsules. The place of performance for this order is Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The period of performance is August 16-17, 2023. This delivery order was issued against an existing DLA pharmaceutical supply contract vehicle to fulfill requirements for Vyvanse, a Schedule...
- The Defense Logistics Agency awarded a $3,017 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of Vyvanse 10 mg. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 14, 2023. Vyvanse, a Schedule II controlled substance, is used to treat attention deficit hyperactivity disorder and binge eating disorder. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle to supply...
- The Defense Logistics Agency Troop Support Medical awarded a $23,705.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562138157 Vyvanse capsules 50mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just one day from September 12, 2023 to September 13, 2023. No major subcontractors or set aside designations were indicated. This delivery order appears to be fulfilling a...
- The Defense Logistics Agency awarded a delivery order valued at $1,337.70 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg on September 16, 2025, with completion scheduled for September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication primarily used to treat attention-deficit/hyperactivity disorder...
- The Defense Logistics Agency awarded a $1,764.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is August 10-11, 2023. Vyvanse is a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder and binge eating disorder. As the Defense Logistics Agency is responsible for worldwide...
- The Defense Logistics Agency awarded a $1,983 delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 30 mg Vyvanse. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by August 4, 2023, with performance beginning on August 3. Vyvanse is a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder and binge eating disorder. The Defense Logistics Agency manages the global supply chain for the...
- The Defense Logistics Agency awarded a $4,561 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 30 mg Vyvanse. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over one day in late July 2023. The purpose of this order is to provide Vyvanse, an amphetamine medication used to treat...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,922 to Amerisourcebergen Drug Corporation for 100 capsules of 20 mg Vyvanse. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is August 22-23, 2023. Vyvanse is a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder and binge eating disorder. The Defense Logistics Agency manages the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA13XDelivery Order
Defense Logistics Agency awarded a $11,853.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 10 mg Vyvanse to be delivered by October 20, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No set-aside provisions were applied to this contract action. Vyvanse is a prescription medication used to treat attention deficit hyperactivity disorder and binge eating disorder. This delivery order was issued against an existing DLA pharmaceutical supply contract vehicle and will provide needed Vyvanse inventory to support the Agency's medical readiness and patient care responsibilities.
Generated 1/18/24, 10:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 10/19/23 |